← #events

Biotech dealmaking and global launches in 2026

02/12/26


As the biotech industry looks ahead to 2027, changes in the global pharmaceutical landscape bring new challenges for dealmaking and international launches.

Join Simon-Kucher experts on 2 December, 15:00–16:00 CET, to discuss the implications of US pricing reforms and European market access changes for asset valuation, licensing negotiations and global launch planning. The webinar will examine how these developments affect commercial expectations, partnership discussions and market entry decisions. Experts will also share practical considerations for biotech companies preparing for licensing deals and international product launches.

Would you like to join? Visit the event website for more information and to register online.